World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000013369
Date of registration: 20/03/2014
Prospective Registration: Yes
Primary sponsor: Hyogo college of medicine
Public title: Efficacy of preoperative oral antibiotics prophylaxis for prevention of surgical site infections in patients with Crohn's disease
Scientific title: Efficacy of preoperative oral antibiotics prophylaxis for prevention of surgical site infections in patients with Crohn's disease - Efficacy of oral antibiotics prophylaxis in patients with Crohn's disease
Date of first enrolment: 2014/04/01
Target sample size: 240
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015539
Study type:  Interventional
Study design:  Parallel Randomized  
Phase:  Phase II
Countries of recruitment
Japan
Contacts
Name:     Motoi Uchino
Address:  1-1 mukogawacho Nishinomiya Hyogo Japan Japan
Telephone: 0798-45-6371
Email: uchino2s@hyo-med.ac.jp
Affiliation:  Hyogo college of medicine Inflammatory bowel disease
Name:     Motoi Uchino
Address:  1-1 Mukogawacho Nishinomiya Hyogo Japan Japan
Telephone: 0798-45-6371
Email: uchino2s@hyo-med.ac.jp
Affiliation:  Hyogo college of medicine Inflammatory bowel disease
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: Emergent surgery. Patients who are not able to orally intake. Patients with drug allergy for kanamycin and 500mg of metronidazole

Age minimum: 20years-old
Age maximum: 70years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Crohn's disease
Intervention(s)
Oral antibiotics will be administrated on the day before surgery (500mg of kanamycin and 500mg of metronidazole at 14:00, 15:00, and 21:00)
without oral antibiotics
Primary Outcome(s)
Incidence of surgical site infection
Secondary Outcome(s)
Incidence of infectious enteritis
Secondary ID(s)
Source(s) of Monetary Support
Hyogo college of medicine
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available: Yes
Date Posted:
Date Completed: 31/03/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history